Journal of Viral Hepatitis

Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
pp. 699-709(11)
Authors: Xirouchakis, E.; Triantos, C.; Manousou, P.; Sigalas, A.; Calvaruso, V.; Corbani, A.; Leandro, G.; Patch, D.; Burroughs, A.

Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
pp. 710-715(6)
Authors: Martín-Carbonero, L.; Puoti, M.; García-Samaniego, J.; De Luca, A.; Losada, E.; Quinzan, G.; Bruno, R.; Mariño, A.; González, M.; Núñez, M.; Soriano, V.

A continuous ¹³C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
pp. 716-728(13)
Authors: Lalazar, G.; Pappo, O.; Hershcovici, T.; Hadjaj, T.; Shubi, M.; Ohana, H.; Hemed, N.; Ilan, Y.

Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance
pp. 729-739(11)
Authors: Brant, L. J.; Hurrelle, M.; Balogun, M. A.; Klapper, P.; Ramsay, M. E.

Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients
pp. 740-746(7)
Authors: Zampino, R.; Ingrosso, D.; Durante-Mangoni, E.; Capasso, R.; Tripodi, M.-F.; Restivo, L.; Zappia, V.; Ruggiero, G.; Adinolfi, L. E.

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients
pp. 747-752(6)
Authors: Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; Keiser, O.; Negro, F.; Meili, D.

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease
pp. 753-760(8)
Authors: Poustchi, H.; Mohamadkhani, A.; Bowden, S.; Montazeri, G.; Ayres, A.; Revill, P.; Farrell, G. C.; Locarnini, S.; George, J.; Malekzadeh, R.

Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors
pp. 761-772(12)
Authors: Jones, K. L.; Brown, L. E.; Eriksson, E. M. Y.; Ffrench, R. A.; Latour, P. A.; Loveland, B. E.; Wall, D. M.; Roberts, S. K.; Jackson, D. C.; Gowans, E. J.